Westchester Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Westchester Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$98.98 - $115.74 $22.9 Million - $26.8 Million	-231,370 Reduced 10.25%	2,026,094 $234 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $20.7 Million - $24.1 Million	214,462 Added 10.5%	2,257,464 $232 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $84.8 Million - $89.7 Million	789,958 Added 63.04%	2,043,002 $223 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $78.2 Million - $143 Million	1,253,044 New	1,253,044 $143 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Westchester Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Westchester Capital Management, LLC with notifications on news.